Research
New studies and research findings from medicine, explained clearly.
-
Asking ChatGPT and Co. About Your Health: What Chatbots Can – and Cannot – Do
Hundreds of millions of people ask AI chatbots about symptoms, lab results or medicines every week. An Oxford study shows why good…
-
Medicine in 50 Years: Repair Instead of Treatment? (2076)
Part 5 of the series “The Future of Medicine”: looking 50 years ahead is above all a look at possibilities. Replacement cells…
-
Medicine in 100 Years: A Thought Experiment for the Year 2126
Part 6 of the series “The Future of Medicine”: what could a doctor in 1926 have predicted about medicine today? A look…
-
AI in Medicine 2026: Where It Really Helps Today – and Where It Doesn’t
Artificial intelligence reads mammograms, writes clinical letters and designs drug candidates. A sober overview of the situation in 2026: what is proven,…
-
First in Humans: Cellular Rejuvenation by Gene Therapy Begins in the Eye
With ER-100, a gene therapy intended to epigenetically “reset” ageing nerve cells in the eye is being tested in humans for the…
-
One Injection, Around 20 Per Cent Longer Life: FGF21 Gene Therapy Rejuvenates Old Mice
Researchers in Barcelona gave old mice a one-off gene therapy injected into the muscle that releases the metabolic hormone FGF21. On average,…
-
Gene Editing Against Heart Attacks: One Infusion Lowers LDL Cholesterol by up to 62 Per Cent
With the base editor VERVE-102, Eli Lilly permanently switches off the cholesterol gene PCSK9 in the liver. New trial data show a…
-
Semaglutide Extends the Lives of Old Mice – Apparently Not Just by Reducing Food Intake
A UC Berkeley study published in Nature shows that old mice given semaglutide lived longer and remained physically and mentally fitter. Calorie…
-
Does Semaglutide Slow the Biological Clock? First Evidence from a Randomised Trial
In a placebo-controlled trial of 108 people with HIV, the active ingredient in Ozempic and Wegovy slowed the pace of biological ageing…
-
435 Million Dollars for Younger Liver Cells: NewLimit Bets on mRNA Reprogramming
The Californian start-up NewLimit has closed one of the largest funding rounds in the longevity sector. It aims to rejuvenate liver cells…
Fachbereiche
- Aesthetic Medicine (16)
- AI in Medicine (5)
- Burn Surgery (2)
- Dermatology (15)
- Dermocosmetics (13)
- Encyclopedia (13)
- Future of Medicine (6)
- Genetics (18)
- Gynaecology (8)
- Hand Surgery (7)
- Longevity (21)
- Medical News (49)
- Neurosurgery (1)
- Nutrition (13)
- Oncology (9)
- Orthopaedics (7)
- Pain Therapy (3)
- Pharma (21)
- Plastic Surgery (10)
- Reconstructive Surgery (12)
- Research (28)
- Surgery (2)
- Wound Management (4)
Themen
